Mabpharm Ltd Sustainability Reports
Mabpharm Limited is a biopharmaceutical company focused on the research, development, and commercialization of innovative drugs and biosimilars, primarily monoclonal antibody drugs, for cancers and autoimmune diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG00P5G4RK7
8 reports from 2019 to 2025
